HCA monthly performance report
Monthly HCA research: returns, drawdown, relative strength, seasonality, and key stats.
HCA monthly report
—
Key takeaways
- HCA Healthcare (HCA) closed August 2026 at $409.64, up 1.75% for the month and +12.60% over the trailing 12 months.
- Year-to-date, HCA is −12.26%, underperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading −10.71% versus its 200-day moving average ($458.78), a cautious technical signal.
- Over the past three years, HCA has underperformed the S&P 500 by −19.83%, with a relative strength index reading of 88.
- Win rate over the trailing 39 months stands at 61.5% — 24 positive months versus 15 negative months.
HCA Healthcare ended August 2026 at $409.64, posting a monthly return of +1.75%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −1.30%.
The current quarter stands at +5.27% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −10.71% versus the 200-day moving average ($458.78).
Year-to-date, HCA is −12.26% against SPY +12.89%, a gap of −25.14%. The stock is currently −26.39% below its 52-week high, with maximum 3-year drawdown at −33.63%.
| Period | HCA | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +2.22% | −0.20% | +2.42% |
| 1 Week | −2.04% | +3.90% | −5.95% |
| 1 Month | +1.75% | +3.05% | −1.30% |
| 3 Months | −5.71% | +7.11% | −12.83% |
| 6 Months |